Dr. POM
ActiveSummary
Dr. POM has been active since 2022 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €133,645 and a net result of €61,249. Equity is growing by about 78% per year across the filed financial years. Its solvency ranks better than 87% of 20,397 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
22-05
NBB filing
Annual accounts filed
financial year 2025 · micro format
2025
31-12
Financial
Highest result from 2023 to 2025net €61,249 ▲18.6%
Operating result €77,407, net result €61,249, both a record.
31-12
Financial
Liquidity more than doubledcurrent ratio 14.63
Current ratio from 5.54 to 14.63; short-term debt falls from €15,954 to €9,879.
31-12
Financial
Equity above €100,000equity €133,645 ▲84.6%
A profit in every financial year since 2023 builds equity to €133,645.
18-06
NBB filing
Annual accounts filed
financial year 2024 · micro format
2024
14-06
NBB filing
Annual accounts filed
financial year 2023 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.